Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer (Q34502198)

2 August 2017

title

Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer (English)

1 reference

2 August 2017

1 reference

Yasuhiro Tada

1

1 reference

2 August 2017

Romulo Martin Brena

2

1 reference

2 August 2017

Björn Hackanson

3

1 reference

2 August 2017

Carl Morrison

4

1 reference

2 August 2017

Gregory A Otterson

5

1 reference

2 August 2017

Christoph Plass

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Journal of the National Cancer Institute

2 August 2017

published in

1 reference

2 August 2017

volume

98

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

396-406

1 reference

Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Lung cancer * 9: Molecular biology of lung cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Gene-promoter hypermethylation as a biomarker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

RASSF1A Promoter Methylation and Kras2 Mutations in Non Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

McBindall--a better name for CCAAT/enhancer binding proteins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Impaired Energy Homeostasis in C/EBPα Knockout Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Methylation-induced repression--belts, braces, and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

C/EBPalpha mutations in acute myeloid leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

Potential of 5-aza-2'-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ093

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ093

1 reference

2 August 2017

1 reference